Roivant Sciences raises $1.1bn to support new subsidiaries

15:40 EDT 11 Aug 2017 | Elsevier Business Intelligence

Roivant Sciences GMBH raised $1.1bn from lead investor SoftBank Vision Fund (the investment arm of Japanese tech giant SoftBa...

Original Article: Roivant Sciences raises $1.1bn to support new subsidiaries


More From BioPortfolio on "Roivant Sciences raises $1.1bn to support new subsidiaries"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...